Evaluating Open Payments

With the enactment of the Affordable Care Act in 2010, pharmaceutical and medical device firms were required to report payments that they make to physicians to the federal government. Administered by the Centers for Medicare & Medicaid Services, the Open Payments program aggregates this payment information and makes it publicly available. To ensure accuracy, physicians can report errors in their reported payments during the Open Payments annual review and dispute period, and drug and device firms will work with physicians to correct any misreporting in the system.